High prevalence of extended-spectrum β-lactamases and plasmid-mediated AmpC β-lactamases in Enterobacteriaceae isolated from long-term care facilities in Korea

Diagnostic Microbiology and Infectious Disease

Volumn 67, Issue 3, 2010, Pages 261-265

  Yoo, Jung Sik ^a   Byeon, Jeonghum ^a   Yang, Jiwoo ^a   Yoo, Jae Il ^a   Chung, Gyung Tae ^a   Lee, Yeong Seon ^a  

^a Korea Centers for Disease Control and Prevention   (South Korea)

Author keywords

Extended spectrum lactamase; Korea; Long term care facility; Plasmid mediated lactamase

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAMASE AMPC; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; PIPERACILLIN; SULTAMICILLIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HEALTH CARE FACILITY; HUMAN; KLEBSIELLA PNEUMONIAE; LONG TERM CARE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SOUTH KOREA;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CROSS INFECTION; DNA PRIMERS; DNA, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LONG-TERM CARE; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; PREVALENCE; REPUBLIC OF KOREA;

EID: 77953684432     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.02.012     Document Type: Article

References (27)

1. Achour N.B., Mercuri P.S., Power P., Belhadj C., Moussa M.B., Galleni M., Belhadj O. First detection of CTX-M-28 in Tunisian hospital from a cefotaxime-resistant Klebsiella pneumoniae strain. Pathol. Biol. 2009, 57:343-348.
2. Apisarnthanrak A., Kiratisin P., Mundy L.M. Clinical and molecular epidemiology of healthcare-associated infections due to extended-spectrum β-lactamases (ESBL)-producing strains of Escherichia coli and Klebsiella pneumoniae that harbor multiple ESBL genes. Infect. Control Hosp. Epidemiol. 2008, 29:1026-1034.
3. Bonomo R.A. Multiple antibiotic-resistant bacteria in long-term-care facilities: an emerging problem in the practice of infectious disease. Clin. Infect. Dis. 2000, 31:1414-1422.
4. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing document, M100-S19 2009, Vol. 29. CLSI, Wayne, PA.
5. Hanson N.D., Moland E.S., Hong S.G., Propst K., Novak D.J., Cavalieri S.J. Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 β-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. community. Antimicrob. Agents Chemother. 2008, 52:3814-3816.
6. Heffernan H., Woodhouse R., Pope C., Blackmore T. Prevalence and types of extended-spectrum β-lactamases among urinary Escherichia coli and Klebsiella spp. in New Zealand. Int. J. Antimicrob. Agents 2009, 34:544-549.
7. Kang J.H., Bae I.K., Kwon S.B., Jeong S.H., Lee J., et al. Prevalence of Ambler class A extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in Korea. Korean J. Clin. Microbiol. 2005, 8:17-25.
8. Kassis-Chikhani N., Vimont S., Asselat K., Trivalle C., Minassian B., Sengelin C., Gautier V., Mathieu D., Dussaix E., Arlet G. CTX-M β-lactamase-producing Escherichia coli in long-term care facilities, France. Emerg. Infect. Dis. 2004, 10:1697-1698.
9. Kingsley J., Verghese S. Sequence analysis of blaCTX-M-28, an ESBL responsible for third-generation cephalosporin resistance in Enterobacteriaceae, for the first time in India. Indian J. Pathol. Microbiol. 2008, 51:218-221.
10. Ko K.S., Lee M.Y., Song J.H., Lee H., Jung D.S., Jung S.I. Prevalence and characterization of extended-spectrum β-lactamase-producing Enterobacteriaceae isolated in Korean hospitals. Diagn. Microbiol. Infect. Dis. 2008, 61:453-459.
11. Lee K.M., Yoo J.I., Yoo Y.S., Yoo J.S., Chung K.T., Ahn T.I., Lee Y.S. Investigation of Klebsiella pneumoniae isolates producing SHV-12 and SHV-11 β-lactamases in Korean hospitals. J. Microbiol. Biotechnol. 2009, 19:1065-1069.
12. Livermore D.M., Canton R., Gniadkowski M., Nordmann P., Rossolini G., Arlet G., Ayala J., Coque T., Kern-Zdanowicz I., Luzzaro F., Poirel L., Woodford N. CTX-M: changing the face of ESBLs in Europe. J. Antimicrob. Chemother. 2007, 59:165-174.
13. Mendelson G., Hait V., Ben-Israel J., Gronich D., Granot E., Raz R. Prevalence and risk factors of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility. Eur. J. Clin. Microbiol. Infect. Dis. 2005, 24:17-22.
14. Migliavacca R., Nucleo E., D'Andrea M., Spalla M., Giani T., Pagani L. Acquired AmpC type beta-lactamase: an emerging problem in Italian long-term care and rehabilitation facilities. New Microbiol. 2007, 30:295-298.
15. Nicolas-Chanoine M., Jarlier V. Extended-spectrum β-lactamases in long-term-care facilities. Clin. Microbiol. Infect. 2008, 14:111-116.
16. Oteo J., Navarro C., Cercenado E., Delgado-Iribarren A., Wilhelmi I., Orden B., Garcia C., Miguelanez S., Perez-Vazquez M., Garcia-Cobos S., Aracil B., Bautista V., Campos J. Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions. J. Clin. Microbiol. 2006, 44:2359-2366.
17. Perez-Perez F., Hanson N.D. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 2002, 40:2153-2162.
18. Philippon A., Arlet G., Jacoby G. Plasmid-determined AmpC-type β-lactamases. Antimicrob. Agents Chemother. 2002, 46:1-11.
19. Rooney P.J., O'Leary M.C., Loughrey A.C., McCalmont S.B., Donaghy P., Badri M., Woodford N., Karisik E., Livermore D.M. Nursing homes as a reservoir of extended-spectrum β-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli. J. Antimicrob. Chemother. 2009, 64:635-641.
20. Ryoo N.H., Kim E.C., Hong S.G., Park Y.J., Lee K., Bae I.K., Song E.H., Jeong S.H. Dissemination of SHV-12 and CTX-M-type extended-spectrum β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea. J. Antimicrob. Chemother. 2005, 56:698-702.
21. Shales D.M., Gerding D.N., John J.F., et al. Society for Healthcare Epidemiology of America and the Infectious Disease Society of America Joint Commission on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect. Control Hosp. Epidemiol. 1997, 18:275-291.
22. Shu J.C., Chia J.H., Kuo A.J., Su L.H., Wu T.L. A 7-year surveillance for ESBL-producing Escherichia coli and Klebsiella pneumoniae at a university hospital in Taiwan: the increase of CTX-M-15 in the ICU. Epidemiol. Infect. 2009, 21:1-11.
23. Song W., Kim J.S., Kim H.S., Yong D., Jeong S.H., Park M.J., Lee K.M. Increasing trend in the prevalence of plasmid-mediated AmpC β-lactamases in Enterobacteriaceae lacking chromosomal ampC gene at a Korean university hospital from 2002 to 2004. Diagn. Microbiol. Infect. Dis. 2006, 55:219-224.
24. Song W., Lee H., Lee K., Jeong S.H., Bae I.K., Kim J.S., Kwak H.S. CTX-M-14 and CTX-M-15 enzymes are the dominant type of extended-spectrum β-lactamase in clinical isolates of Escherichia coli from Korea. J. Med. Microbiol. 2009, 58:261-266.
25. Warren R.E., Harvey G., Carr R., Ward D., Doroshenko A. Control of infections due to extended-spectrum β-lactamases-producing organisms in hospitals and the community. Clin. Microbiol. Infect. 2008, 14:124-133.
26. Yu Y., Ji S., Chen Y., Zhou W., Zm W.e.i., Li L., Ma Y. Resistance of strains producing extended-spectrum β-lactamases and genotype distribution in China. J. Infect. 2007, 54:53-57.
27. Yum J.H., Kim S., Lee H., Yong D., Lee K., Cho S.N., Chong Y. Emergence and wide dissemination of CTX-M-type ESBLs, and CMY-2- and DHA-1-type AmpC β-lactamases in Korean respiratory isolates of Klebsiella pneumoniae. J. Korean Med. Sci. 2005, 20:961-965.